Jiangsu Nanfang Medical Strategic Asset Allocation Index
Jiangsu Nanfang Medical strategic asset allocation index. Jiangsu Nanfang Medical (603880) has a Strategic Asset Allocation Index of 99.1% as of June 2023. Strategic assets (PP&E of CN¥623.57 Million plus long-term investments of CN¥-) total CN¥623.57 Million, measured against net assets of CN¥629.44 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Jiangsu Nanfang Medical net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Jiangsu Nanfang Medical (2014–2021)
Strategic asset allocation index of Jiangsu Nanfang Medical from 2014 to 2021. This chart shows how Jiangsu Nanfang Medical's Strategic Asset Allocation Index has evolved across 8 annual periods from 2014 to 2021. As of June 2023, the index stands at 99.1%, representing strategic assets of CN¥623.57 Million against net assets of CN¥629.44 Million CNY. Check 603880 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Jiangsu Nanfang Medical Strategic Asset Allocation Index by Year (2014–2021)
Jiangsu Nanfang Medical strategic asset allocation index by year from 2014 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Jiangsu Nanfang Medical from 2014 to 2021, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Jiangsu Nanfang Medical market cap and net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 79.2% | CN¥518.73 Million | CN¥518.73 Million | CN¥- | CN¥654.90 Million | ▲ +36.4 pp |
| 2020 | 42.8% | CN¥299.84 Million | CN¥299.84 Million | CN¥- | CN¥700.80 Million | ▼ -3.2 pp |
| 2019 | 46.0% | CN¥260.86 Million | CN¥260.86 Million | CN¥- | CN¥567.52 Million | ▲ +17.4 pp |
| 2018 | 28.5% | CN¥159.77 Million | CN¥159.77 Million | CN¥- | CN¥560.04 Million | ▲ +4.8 pp |
| 2017 | 23.7% | CN¥127.40 Million | CN¥127.40 Million | CN¥- | CN¥537.57 Million | ▼ -13.9 pp |
| 2016 | 37.6% | CN¥96.46 Million | CN¥96.46 Million | CN¥- | CN¥256.69 Million | ▲ +12.0 pp |
| 2015 | 25.6% | CN¥56.89 Million | CN¥56.89 Million | CN¥- | CN¥222.51 Million | ▼ -3.3 pp |
| 2014 | 28.9% | CN¥60.96 Million | CN¥60.96 Million | CN¥- | CN¥210.90 Million | — |